Pruritus Clinical Trials

9 recruiting

Pruritus Trials at a Glance

16 actively recruiting trials for pruritus are listed on ClinicalTrialsFinder across 6 cities in 21 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Fargo, Hangzhou, and Baltimore. Lead sponsors running pruritus studies include Galderma R&D, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, and Assistance Publique - Hôpitaux de Paris.

Browse pruritus trials by phase

Treatments under study

About Pruritus Clinical Trials

Looking for clinical trials for Pruritus? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pruritus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pruritus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Phase 2

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

Chronic Kidney DiseasesPruritus
Vifor Fresenius Medical Care Renal Pharma18 enrolled14 locationsNCT06593392
Recruiting
Phase 2

Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)

Chronic Pruritus of Unknown Origin
Galderma R&D50 enrolled24 locationsNCT07074977
Recruiting
Phase 3

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

Pruritus
Sanofi284 enrolled91 locationsNCT05263206
Recruiting
Not Applicable

Effect of Hand Massage on Chronic Kidney Disease Associated Pruritus in Patients Receiving Hemodialysis

Chronic Kidney Disease Associated Pruritus
University of Applied Sciences of Western Switzerland54 enrolled4 locationsNCT07312916
Recruiting
Not Applicable

VR-PMR for Post-Burn Symptoms

Virtual RealityAnxietyDepressive Symptoms+8 more
Johns Hopkins University34 enrolled1 locationNCT07317271
Recruiting
Phase 2

TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus

Immunotherapy-related Pruritus
University of California, San Diego28 enrolled1 locationNCT06748404
Recruiting
Not Applicable

Evaluation of the Prevalence of BP180 and BP230 Autoantibodies in the Serum of Patients With Pruritus Under Immunotherapy

Patients With Chronic Pruritus for More Than 1 Month Who Have Received Immunotherapy
University Hospital, Rouen100 enrolled1 locationNCT05689463
Recruiting
Phase 4

Efficacy of Pregabalin for Diabetic Pruritus - A Randomized Controlled Study.

Diabetic PruritusEfficacy of Pregabalin in Controlling Diabetic Pruritus Severity
Post Graduate Institute of Medical Education and Research, Chandigarh46 enrolled2 locationsNCT06790537
Recruiting
Not Applicable

Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch

Pruritus
Mayo Clinic12 enrolled1 locationNCT06751056
Recruiting
Not Applicable

Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

Peritoneal DialysisAdverse EventModerate-to-severe Pruritus+1 more
Guangdong Provincial People's Hospital93 enrolled1 locationNCT07098351
Recruiting
Phase 4

Comparison of Pruritus Incidence After Intrathecal Morphine 0.1 vs 0.2 mg in Cesarean Section

Pruritus Caused by Drug
Khon Kaen University69 enrolled2 locationsNCT07054775
Recruiting
Not Applicable

Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and Pruritus

PsoriasisPruritus
Pierre Fabre Dermo Cosmetique40 enrolled1 locationNCT06800755
Recruiting
Phase 1

Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section

Pruritus Caused by Drug
Wayne State University66 enrolled1 locationNCT06297499
Recruiting

Swiss Itch Registry

Pruritus
University Hospital, Basel, Switzerland100 enrolled1 locationNCT06120907
Recruiting
Not Applicable

Effects of Acupuncture for Senile Pruritus

Senile Pruritus
Guang'anmen Hospital of China Academy of Chinese Medical Sciences108 enrolled1 locationNCT06506240
Recruiting
Not Applicable

Meditation in Inflammatory Dermatosis

Atopic DermatitisPsoriasisPruritus
Assistance Publique - Hôpitaux de Paris72 enrolled1 locationNCT05500794